RheOx Registry Study in Europe

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 9, 2020

Primary Completion Date

December 15, 2024

Study Completion Date

December 15, 2025

Conditions
Chronic BronchitisCOPD
Interventions
DEVICE

RheOx

RheOX is a CE-marked device-based, energy delivery system that delivers energy to ablate soft tissue such as the airway epithelium and sub-mucosal tissue layers. The energy is delivered via a proprietary catheter through the bronchoscope.

Trial Locations (2)

69047

RECRUITING

Pneumologie Thoraxklinik Heidelberg gGmbH University of Heidelberg, Heidelberg

A-1140

RECRUITING

Otto Wagner Spital, Vienna

Sponsors
All Listed Sponsors
lead

Gala Therapeutics, Inc.

INDUSTRY